Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Söderåkra Cardiovascular Risk Factor Study-Reference-Cited by-同舟云学术

Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Söderåkra Cardiovascular Risk Factor Study

Published:2009-06 Issue:3 Volume:35 Page:198-205
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Petersson U.,Östgren C.J.,Brudin L.,Brismar K.,Nilsson P.M.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference35 articles.

1. Insulin-like growth factor binding proteins: interactions with IGFs and intrinsic bioactivities;Baxter;Am J Physiol Endocrinol Metab,2000

2. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations;Heald;Diabetologia,2001

3. Low serum insulin-like growth factor-binding protein-1 is associated with an unfavourable cardiovascular risk profile in elderly men;Harrela;Ann Med,2000

4. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin-dependent diabetes mellitus (NIDDM);Gibson;J Clin Endocrinol Metab,1996

5. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease;Janssen;Arterioscler Thromb Vasc Biol,1998

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 5:2 Diet Affects Markers of Insulin Secretion and Sensitivity in Subjects with and without Type 2 Diabetes—A Non-Randomized Controlled Trial;International Journal of Molecular Sciences;2024-09-08

2. Salvianolic acid A attenuates non-alcoholic fatty liver disease by regulating the AMPK-IGFBP1 pathway;Chemico-Biological Interactions;2024-09

3. The impact of insulin resistance and glycaemic control on Insulin like growth factor-1 in patients with type 2 diabetes: A cross sectional study;2024-06-13

4. IGF-1 and IGFBP-1 as Possible Predictors of Response to Lifestyle Intervention—Results from Randomized Controlled Trials;International Journal of Molecular Sciences;2024-06-10

5. Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes;Nature Medicine;2024-04-16